Google gives a 7-day warning before suspending an account under the Unapproved Substances policy. Here's how to build a system that never misses it.
Buried inside Google's Unapproved Substances policy is a line most peptide brands never notice until it's too late to use: "a warning will be issued at least 7 days prior to any suspension of your account." That's not a formality — it's a genuine window to fix a problem before it becomes an account-ending one. The brands that never get blindsided by a suspension are, almost without exception, the ones that treat this warning system as something to actively monitor, not something to react to after the fact.
Here's what that actually looks like in practice.
Policy warnings don't always arrive as a dramatic red banner. They typically surface in three places, and brands that only check one of them are the ones who miss it:
The single most common failure mode we see in account audits isn't a brand ignoring a warning — it's a brand never having a defined owner responsible for checking for one.
A policy status check shouldn't be an occasional task someone remembers to do after something feels off. Here's the cadence that holds up in accounts we manage:
None of this requires special tooling — it requires treating policy status as an operational metric with the same seriousness as spend or conversion rate, not as background noise.
Once a warning shows up, the seven-day clock is running, and the two available paths are the same ones covered in the main policy breakdown: edit to comply, or appeal. Speed and diagnosis matter more than either individual path:
Generic e-commerce categories rarely deal with this level of policy scrutiny, so many agencies and in-house teams built their operating habits in categories where a policy warning is a rare event. Peptide and research chemical brands operate in one of the highest-scrutiny categories on the platform — see the scale of the enforcement trend in our breakdown of the Unapproved Substances policy and LegitScript's own data on rising peptide ad enforcement. Treating policy monitoring as a standing operational habit, rather than a reactive one, is one of the highest-leverage, lowest-cost things a peptide brand can do for account longevity.
The policy specifies this window for suspensions tied to the Unapproved Substances policy specifically. Other policy areas, including some circumventing-systems violations, can carry different — sometimes immediate — enforcement timelines, so this shouldn't be treated as a universal grace period across every possible violation type.
Whoever has direct daily access to the Google Ads account and the authority to pause or edit campaigns without waiting for approval — typically the person running paid media day-to-day, not a founder or executive who only checks in periodically.
Yes, and it's one of the more valuable, lower-visibility parts of ongoing account management in this category — but it only works if the agency has full account access and a defined daily check process, not just campaign-level access.
Occasionally the stated policy reason is broad. In those cases, cross-referencing the flagged asset against the specific restricted categories in the Unapproved Substances policy usually narrows it down faster than waiting on Google Ads support.
See how a compliant account went from launch to sustained scale without a single policy flag.
Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.
Book a Free Audit